224 related articles for article (PubMed ID: 12723505)
1. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
Mommens V; Bosquée L; D'Orio V
Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
[TBL] [Abstract][Full Text] [Related]
2. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
Pavlakis N; Bell DR; Millward MJ; Levi JA
Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
Hansen HH; Sørensen JB
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
Vander Els NJ; Miller V
Chest; 1998 Dec; 114(6):1779-81. PubMed ID: 9872221
[TBL] [Abstract][Full Text] [Related]
5. [Severe interstitial pneumonitis related to Gemcitabine].
Sabria-Trias J; Bonnaud F; Sioniac M
Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
[TBL] [Abstract][Full Text] [Related]
6. An autopsy case of acute pulmonary toxicity associated with gemcitabine.
Maniwa K; Tanaka E; Inoue T; Kato T; Sakuramoto M; Minakuchi M; Maeda Y; Noma S; Kobashi Y; Taguchi Y
Intern Med; 2003 Oct; 42(10):1022-5. PubMed ID: 14606719
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-induced severe pulmonary toxicity.
Barlési F; Villani P; Doddoli C; Gimenez C; Kleisbauer JP
Fundam Clin Pharmacol; 2004 Feb; 18(1):85-91. PubMed ID: 14748759
[TBL] [Abstract][Full Text] [Related]
8. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
Abratt RP; Hacking DJ; Goedhals L; Bezwoda WR
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
[TBL] [Abstract][Full Text] [Related]
9. High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
Kouroussis C; Mavroudis D; Kakolyris S; Voloudaki A; Kalbakis K; Souglakos J; Agelaki S; Malas K; Bozionelou V; Georgoulias V
Lung Cancer; 2004 Jun; 44(3):363-8. PubMed ID: 15140550
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.
Chen YM; Chen MC; Tsai CM; Perng RP
Lung Cancer; 2003 Apr; 40(1):99-101. PubMed ID: 12660014
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer.
Gatzemeier U; Manegold C; Eberhard W; Wilke HJ; Chomy F; Chomy P; Khayat D; Blatter J; Seeber S; Drings P
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-36-S8-38. PubMed ID: 9207315
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
[TBL] [Abstract][Full Text] [Related]
13. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study.
Ng EW; Sandler AB; Robinson L; Einhorn LH
Am J Clin Oncol; 1999 Dec; 22(6):550-3. PubMed ID: 10597737
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of gemcitabine plus cisplatin in non-small cell lung cancer: a Hoosier Oncology Group study.
Einhorn LH
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-24-S8-26. PubMed ID: 9207312
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of gemcitabine in lung cancer: part I.
Bunn PA
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-1. PubMed ID: 9194472
[No Abstract] [Full Text] [Related]
18. Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer.
Shepherd FA; Abratt RP; Anderson H; Gatzemeier U; Anglin G; Iglesias J
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-50-S7-55. PubMed ID: 9194481
[TBL] [Abstract][Full Text] [Related]
19. Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC).
Ferrigno D; Buccheri G;
Lung Cancer; 2004 Sep; 45(3):373-80. PubMed ID: 15301878
[TBL] [Abstract][Full Text] [Related]
20. Single-agent gemcitabine in non-small cell lung cancer: the French experience.
Le Chevalier T; Gottfried M
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-47-S7-49. PubMed ID: 9194480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
